Marita Kesrouani
About Marita Kesrouani
Marita Kesrouani is a Global Brand Manager specializing in Anaesthesia, Intensive Care, and Emergency Medicine, with extensive experience in the medical device sector and pharmaceutical marketing. She has worked with various companies, including Merck, B. Braun Group, and Fresenius Kabi, and holds degrees from HEC Paris and Université Saint Joseph.
Current Role at Laboratoire Aguettant
Marita Kesrouani serves as the Global Brand Manager for Anaesthesia, Intensive Care, and Emergency Medicine at Laboratoire Aguettant. She has held this position since 2021, contributing to the development and management of brand strategies within these critical medical fields.
Previous Experience in the Medical Device Sector
Kesrouani has extensive experience in the medical device sector, particularly focusing on dialysis products. Her career includes roles at various companies, such as B. Braun Group, where she worked as Chef de gamme dialyse from 2014 to 2015, and Fresenius Kabi as International Product Manager for Chronic Kidney Disease from 2019 to 2020.
Educational Background in Pharmacy and Marketing
Marita Kesrouani studied at Université Saint Joseph, earning a Doctorat d'exercice en Pharmacie from 2006 to 2011. She furthered her education at HEC Paris, where she achieved an MS in Marketing Intelligence from 2011 to 2012, equipping her with a robust foundation in both pharmacy and marketing.
Expertise in Pharmaceutical Marketing
Kesrouani possesses a unique combination of pharmaceutical and marketing expertise. Her focus includes hospital products and virology, particularly in relation to HIV and HCV. She has also developed marketing strategies for pharmaceutical products addressing rare pulmonary diseases, specifically alpha-1 antitrypsin deficiency.
Career Progression in Pharmaceutical Companies
Throughout her career, Kesrouani has held various positions in notable pharmaceutical companies. She worked at MSD France SAS as Chef de produit Virologie from 2012 to 2013, at LFB as Chef de produit Alfalastin from 2016 to 2019, and at Le Monde Pharmaceutique as Chef de Projets et Ingénieur d'Affaires from 2013 to 2014.